论文部分内容阅读
目的:分析评价腹腔镜下子宫肌瘤剔除术前应用垂体后叶素的可行性。方法:随机选取医院收治的2013年1月至2015年1月50例子宫肌瘤患者,并且依据治疗方法的不同,分为研究组(25例)、对照组(25例)。给予对照组子宫肌瘤患者临床中,在其行腹腔镜下子宫肌瘤剔除术前,不应用垂体后叶素治疗,研究组中患者,采取腹腔镜下子宫肌瘤剔除术前应用垂体后叶素,对比两组患者临床手术疗效,分析应用垂体后叶素的可行性。结果:对于研究组中患者,临床在腹腔镜下子宫肌瘤剔除术前应用垂体后叶素治疗后,明显改善患者临床疗效,在手术时间、术中出血量、并发症方面,均显著优于对照组(P<0.05)。结论:在临床治疗子宫肌瘤患者中,对其在腹腔镜下子宫肌瘤剔除术前应用垂体后叶素,发挥一定可行性,有助于改善临床手术疗效,垂体后叶素不仅可以减少术中出血量,还可降低术后并发症率,发挥积极手术疗效。
Objective: To evaluate the feasibility of applying pituitrin before laparoscopic myomectomy. Methods: Fifty patients with uterine fibroids from January 2013 to January 2015 were randomly selected and divided into study group (25 cases) and control group (25 cases) according to the different treatment methods. To the control group of patients with uterine fibroids, laparoscopic myomectomy before surgery in patients with pituitrin treatment should not be applied to patients in the study group to take laparoscopic myomectomy before pituitary application The clinical efficacy of the two groups of patients was compared and the feasibility of applying pituitrin was analyzed. Results: For patients in the study group, clinical application of pituitrin before laparoscopic myomectomy significantly improved the clinical efficacy of patients, and were significantly superior to those in operation time, intraoperative blood loss and complications Control group (P <0.05). Conclusion: In the clinical treatment of uterine fibroids, the application of pituitrin before laparoscopic myomectomy, play a certain feasibility, will help to improve the efficacy of clinical surgery, pituitary vasopressin can not only reduce the operation In the amount of bleeding, but also reduce postoperative complications, play a positive surgical effect.